Stress & Sleep Science

The HPA Axis: How Cortisol Regulation Works

The hypothalamic-pituitary-adrenal axis is your stress control system. When its cortisol rhythm breaks down, sleep and recovery break with it. This is the mechanism — and the nutrients with verified EFSA support.

Moana Natura Research Team··12 min read

Notice: This article is for educational purposes. It does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before starting any supplementation protocol.

The HPA axis — hypothalamic-pituitary-adrenal axis — is the chain of communication that runs your entire stress response. The hypothalamus detects a stressor, signals the pituitary gland, which signals the adrenal glands, which release cortisol into your bloodstream. It is fast, evolutionarily ancient, and was built for short bursts of acute danger — not for a working week that does not end.

Cortisol is not the enemy. In the right amount, at the right time of day, it is what gets you out of bed, focused, and functional. The problem is not cortisol existing. The problem is cortisol losing its rhythm.

The Cortisol Rhythm: Why Timing Is Everything

In a healthy system, cortisol follows a clean daily curve. It peaks in the early morning — roughly 06:00–08:00 — which is what actually wakes you up, more than any alarm. It declines steadily through the day. By evening it should be low. By the time you are trying to fall asleep, it should be at its lowest point in the 24-hour cycle.

This curve is why morning people exist. It is not personality — it is cortisol timing. When the curve is intact, falling asleep is straightforward because your body is biochemically prepared for it. Low evening cortisol clears the path for sleep-onset to proceed without resistance.

HPA Dysregulation: What Happens When the Rhythm Breaks

Chronic stress flattens this curve. Instead of a clean peak-and-decline, cortisol stays elevated into the evening — sometimes spiking right when it should be at its lowest. This is why “tired but wired” is a real physiological state, not an expression. You are exhausted and your body will not let you sleep, because hormonally it still thinks something is wrong.

The pattern — elevated evening cortisol, blunted morning cortisol — is the signature of a dysregulated HPA axis. It does not stay contained to feeling tired. It cascades:

  • Sleep architecture: Elevated cortisol suppresses deep sleep stages and REM, and triggers micro-arousals — brief wake-ups lasting 3–15 seconds that never register in conscious memory but fragment recovery at a measurable level.
  • Metabolic function: Cortisol raises blood glucose via gluconeogenesis. Chronically elevated cortisol — particularly at night — is associated with higher fasting glucose and impaired glucose stability.
  • Immune function: Short-term cortisol spikes are anti-inflammatory. Sustained high cortisol produces the opposite — a low-grade, persistent inflammatory state linked to accelerated cellular ageing.
  • Psychological function: High dysregulated cortisol interferes with mood regulation and cognitive clarity. The irritability, shortened patience, and difficulty concentrating under chronic stress are hormonal, not character-based.

The Three-Stage Cortisol Curve Failure

HPA axis dysfunction typically progresses through recognizable stages:

  1. Elevated phase: Cortisol is high across most of the day, including evenings. Sleep onset is slow; morning energy feels borrowed rather than genuine. This is the most common presentation in people under sustained occupational or psychological stress.
  2. Flattening phase: The curve loses its amplitude — cortisol is neither properly high in the morning nor properly low at night. The result is persistent flatness: no energy peak in the morning, no clear wind-down in the evening.
  3. Blunted phase: Morning cortisol fails to rise to a functional peak. Waking up is difficult, morning cognition is poor, and the body cannot sustain consistent energy across the day. This phase is often misread as a mood or motivation problem when it is physiological.

Nutrients with EFSA-Authorized Claims Relevant to HPA Function

EU Regulation 432/2012 defines the conditions under which specific health claims may be made for food supplements in the European Union. The following claims are authorized verbatim and apply directly to the nutrients relevant to HPA axis function.

Table 1 — EFSA-authorized claims for HPA-relevant nutrients (EU Regulation 432/2012)
NutrientAuthorized claimEntry IDs
MagnesiumMagnesium contributes to normal psychological function.ID 364
MagnesiumMagnesium contributes to the reduction of tiredness and fatigue.IDs 244, 245, 246
MagnesiumMagnesium contributes to normal functioning of the nervous system.ID 374
Vitamin B6Vitamin B6 contributes to normal psychological function.IDs 77, 78
Vitamin B6Vitamin B6 contributes to normal functioning of the nervous system.IDs 68, 70
Pantothenic acidPantothenic acid contributes to normal mental performance.IDs 57, 58
Pantothenic acidPantothenic acid contributes to normal synthesis and metabolism of steroid hormones.ID 56

Claims may be used only for products that qualify as a source of the respective nutrient under Annex to Regulation (EC) No 1924/2006. These are verbatim authorized claims — not marketing language.

One important clarification: there is no EFSA-authorized claim for magnesium and sleep specifically. The claim that is authorized covers psychological function and the reduction of tiredness and fatigue — related, but not the same as a “sleep supplement” claim. Supplements that state magnesium “helps you sleep” are making an unauthorized claim. The authorized wording is the only wording with EU regulatory backing.

Magnesium and the HPA Axis: The Mechanism

Magnesium plays a direct role in regulating HPA axis activity. The hypothalamus contains NMDA receptors — the same glutamate receptors involved in stress amplification — and magnesium acts as a physiological blocker of these receptors. When magnesium status is low, NMDA receptor activity increases, which facilitates greater HPA activation in response to the same stressor. In plain terms: magnesium deficiency amplifies the stress response.

The relationship runs in both directions. Stress accelerates urinary magnesium excretion — the same stress response that depletes magnesium also becomes harder to regulate without adequate magnesium. This creates a documented cycle: chronic stress depletes magnesium, low magnesium amplifies stress reactivity, amplified stress depletes more magnesium.

Magnesium also participates in the synthesis of GABA, the primary inhibitory neurotransmitter that reduces neuronal excitability. Low magnesium is associated with reduced GABAergic tone — a more excitable nervous system, consistent with the clinical picture of someone who is exhausted but cannot disengage.

Why Delivery Format Matters for Magnesium

Standard magnesium supplements — oxide, sulfate — have absorption rates of 4–30% depending on form and gastric conditions. Magnesium oxide, the cheapest and most common form, is at the lower end of that range. A large fraction of what is taken passes through unabsorbed.

Magnesium L-threonate and magnesium glycinate achieve meaningfully higher absorption than oxide forms, with the L-threonate form specifically demonstrated to cross the blood-brain barrier in animal models — relevant given that the primary mechanism of interest (NMDA receptor modulation, GABAergic support) occurs centrally.

Liposomal delivery — encapsulating magnesium in a phospholipid bilayer — provides a further mechanism: the liposome bypasses standard transporter-mediated absorption routes and fuses directly with intestinal epithelial cells, allowing absorption independent of transporter saturation. This is the delivery mechanism used in Moana Natura’s HPA Calm formula.

The Botanical Question: Why No Ashwagandha

A note on what the formula does not contain. Ashwagandha (Withania somnifera) is widely marketed for stress and cortisol support. No botanical health claim has ever received EFSA authorization — the entire category has been held in suspension since 2010 because the evidence standards required for authorization have not been met at the EU level.

Beyond the lack of authorized claims, ashwagandha has drawn safety scrutiny from multiple EU national authorities. Denmark restricts it. The UK Food Standards Agency has flagged specific populations for which use is not recommended. Building an HPA axis support formula on a nutrient with authorized regulatory backing and a clean safety profile is a different decision than adding an ingredient that trends on wellness platforms.

The EFSA-authorized nutrients — magnesium, vitamin B6, pantothenic acid — are not as marketable as “clinically studied ashwagandha.” They also have thirty years of mechanistic research and the formal backing of the European Food Safety Authority. The choice is intentional.

Summary: What the HPA Axis Needs

The HPA axis regulates cortisol. Cortisol regulates sleep onset, metabolic function, immune modulation, and psychological resilience. When the axis loses its rhythm under chronic stress, the downstream effects span every system that depends on a properly timed hormonal environment.

Nutritional support for the HPA axis is not about “reducing stress” in an abstract sense. It is about providing the specific cofactors — magnesium, vitamin B6, pantothenic acid — that the nervous system and adrenal system require to maintain normal function under load. The EFSA-authorized claims for these nutrients reflect this: normal psychological function, normal functioning of the nervous system, reduction of tiredness and fatigue, normal mental performance, normal synthesis and metabolism of steroid hormones.